ConductScience.org, home

Paper33465313

Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort.

Blankenship CM and 8 others. Am J Audiol, 2021. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort. Papers, record 33465313. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33465313

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort.
PubMed
Journal
Am J Audiol
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
2.63
iCite
Revised in PubMed
2022-07-16
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Blankenship CMChelsea Mhttps://orcid.org/0000-0003-2355-7920
2Hunter LLLisa L
3Feeney MPM Patrick
4Cox MMadison
5Bittinger LLindsey
6Garinis ACAngela C
7Lin LLi
8McPhail GGary
9Clancy JPJohn P

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
Speech PerceptionMajor topic
Adolescent
Aminoglycosides
Anti-Bacterial Agents
Child
Cross-Sectional Studies
Hearing Loss, High-Frequency
Humans
Young Adult

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DC010202NIDCD NIH HHSUnited StatesR01DC010202PubMedNIH RePORTER
UL1 TR001425NCATS NIH HHSUnited StatesUL1TR001425PubMedNIH RePORTER

Download CSV of grants

References78

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121234508Low prevalence of middle ear disease in cystic fibrosis patients.J Pediatr (Rio J)2011https://conductscience.org/library/papers/21234508PubMed
26487144Extended high-frequency hearing loss in children with cleft palate.Audiology1984https://conductscience.org/library/papers/6487144PubMed
426480907High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients.Braz J Otorhinolaryngol2015https://conductscience.org/library/papers/26480907PubMed
529800354Children's Speech Perception in Noise: Evidence for Dissociation From Language and Working Memory.J Speech Lang Hear Res2018https://conductscience.org/library/papers/29800354PubMed
65422338The hearing of patients with cystic fibrosis.Arch Otolaryngol1970https://conductscience.org/library/papers/5422338PubMed
728012509Changes in the inner ear structures in cystic fibrosis patients.Int J Pediatr Otorhinolaryngol2017https://conductscience.org/library/papers/28012509PubMed
818929686Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.J Biomed Inform2009https://conductscience.org/library/papers/18929686PubMed
928474732The Nephrotoxicity of Vancomycin.Clin Pharmacol Ther2017https://conductscience.org/library/papers/28474732PubMed
1029062271Aminoglycoside-Induced Cochleotoxicity: A Review.Front Cell Neurosci2017https://conductscience.org/library/papers/29062271PubMed
1129914288Progressive Hearing Loss among Patients with Cystic Fibrosis and Parenteral Aminoglycoside Treatment.Otolaryngol Head Neck Surg2018https://conductscience.org/library/papers/29914288PubMed
122816859Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry.Am J Dis Child1989https://conductscience.org/library/papers/2816859PubMed
13287328Inflammatory middle ear diseases in patients with cystic fibrosis.Acta Otolaryngol Suppl1979https://conductscience.org/library/papers/287328PubMed
1410628715Histopathologic features of the temporal bone in patients with cystic fibrosis.Arch Otolaryngol Head Neck Surg2000https://conductscience.org/library/papers/10628715PubMed
1529093664Towards the Prevention of Aminoglycoside-Related Hearing Loss.Front Cell Neurosci2017https://conductscience.org/library/papers/29093664PubMed
1633661027Wideband Acoustic Reflex Growth in Adults With Cystic Fibrosis.Am J Audiol2021https://conductscience.org/library/papers/33661027PubMed
177054134Acoustic reflex after experimental lesions to inner and outer hair cells.Hear Res1982https://conductscience.org/library/papers/7054134PubMed
188836818Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis.J Antimicrob Chemother1996https://conductscience.org/library/papers/8836818PubMed
193885674Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin.Acta Paediatr Scand1985https://conductscience.org/library/papers/3885674PubMed
206637463Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection.Acta Paediatr Scand1983https://conductscience.org/library/papers/6637463PubMed
2117266591Aminoglycoside-induced ototoxicity.Curr Pharm Des2007https://conductscience.org/library/papers/17266591PubMed

See all 78 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42173068Speech-in-noise difficulties in aminoglycoside ototoxicity reflects combined afferent and efferent dysfunction.Hear Res2026https://conductscience.org/library/papers/42173068PubMed
40583133Wideband Middle-Ear Measures in Aminoglycoside-Exposed Adults with Cystic Fibrosis.Ear Hear2025https://conductscience.org/library/papers/40583133PubMed
40233985Improving ototoxicity monitoring in patients receiving aminoglycosides using a novel digital approach: a quality improvement project.BMJ Open Qual2025https://conductscience.org/library/papers/40233985PubMed
40161561What's New in Ototoxicity Management?Perspect ASHA Spec Interest Groups2024https://conductscience.org/library/papers/40161561PubMed
39935234Investigating the Potential Hearing Impairment and Ototoxicity in Children up to Six Years With Cystic Fibrosis After Aminoglycoside Exposure (PIANO-CF Extension).Pediatr Pulmonol2025https://conductscience.org/library/papers/39935234PubMed
39261989Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment.Ear Hear2025https://conductscience.org/library/papers/39261989PubMed
38333844Aminoglycoside-induced sensorineural hearing loss in pediatric cystic fibrosis patients: A retrospective cohort study.Heliyon2024https://conductscience.org/library/papers/38333844PubMed
37014872Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.PLoS One2023https://conductscience.org/library/papers/37014872PubMed
36925655The Rise and Fall of Aural Acoustic Immittance Assessment Tools.Semin Hear2023https://conductscience.org/library/papers/36925655PubMed
36709582Brainstem auditory physiology in children with listening difficulties.Hear Res2023https://conductscience.org/library/papers/36709582PubMed
34917943Aminoglycoside- and glycopeptide-induced ototoxicity in children: a systematic review.JAC Antimicrob Resist2021https://conductscience.org/library/papers/34917943PubMed
34606329Ototoxicity and Noise Damage: From Preclinical Findings to Audiological Management.Am J Audiol2021https://conductscience.org/library/papers/34606329PubMed
34549989Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic Fibrosis.Am J Audiol2021https://conductscience.org/library/papers/34549989PubMed
34379758Pharmacokinetic modelling to predict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis.J Antimicrob Chemother2021https://conductscience.org/library/papers/34379758PubMed
34261857Listening Difficulties in Children With Normal Audiograms: Relation to Hearing and Cognition.Ear Hear2021https://conductscience.org/library/papers/34261857PubMed
33661027Wideband Acoustic Reflex Growth in Adults With Cystic Fibrosis.Am J Audiol2021https://conductscience.org/library/papers/33661027PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33465313

GET https://conductscience.org/api/papers/v1/33465313/references?page=2